Recent news on Glofil-125.

Questcor Announces Financial Results for 2006 Third Quarter  Nov 2, 2006
...the three and nine months ended September 30, 2006 included the sale of Questcor’s non-core products Nascobal ® , Ethamolin ® and Glofil ® -125 and the ... -Business Wire (press release),

Questcor Announces Financial Results for the First Quarter of 2006 ...  May 9, 2006
R), Ethamolin(R), Glofil(R)-125,and VSL#3(R). As previously reported, Questcor sold its non-coreproducts Nascobal, Ethamolin, and Glofil-125 in October 2005 to ... - Finanzen.net





Questcor Announces Financial Results for 2005 and the Expansion of ...  Mar 9, 2006
...product sales included a full quarter of Acthar net product sales, but less than one month of net product sales of Nascobal, Ethamolin and Glofil-125 due to ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional